Although both study groups showed a statistically significant decrease at six months compared with baseline -LRB--14.1 mmHg for renal denervation compared to -11.7 mmHg for the sham treatment control), the difference of -2.29 mmHg in
office systolic blood pressure between the two arms was not significant.
Not exact matches
(1) Resistant hypertension (rHTN) is defined as
office blood pressure greater than 160/90 mmHg,
systolic ambulatory blood pressure greater than 135 mmHg and failure to respond to more than 3 appropriate drugs at the highest tolerated doses including diuretics.
Renal denervation failed to achieve the primary efficacy endpoint of a decrease in
systolic blood pressure measured in the doctor's
office from baseline to six months or the powered secondary efficacy endpoint of decrease in average 24 - hour levels by ambulatory blood pressure monitoring, which provides more reliable readings.